Kindred biosciences, inc. (KIN)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12
Cash Flows from Operating Activities
Net loss

-68,095

-61,389

-61,096

-58,840

-55,774

-49,690

-43,979

-38,832

-34,358

-30,879

-26,958

-24,751

-22,931

-22,499

-23,110

-24,522

-26,458

-27,130

-27,499

-26,476

-27,703

-27,139

-22,733

-17,871

-10,157

-4,213

-1,950

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense

7,561

7,357

7,293

7,102

6,613

6,277

5,902

5,583

5,490

5,207

4,805

4,504

4,106

3,627

3,753

3,744

3,841

4,157

4,007

4,266

4,423

4,422

3,936

3,077

1,960

922

515

0

0

0

Depreciation and amortization expense

3,092

2,539

2,039

1,576

1,161

805

707

637

573

475

335

242

163

155

153

149

150

146

137

117

88

58

0

0

0

-

0

0

0

-

Loss/(gain) on disposal of property and equipment

-211

-212

-180

-168

-35

-34

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of discount on marketable securities

541

513

458

336

231

179

152

75

-45

-162

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of debt discount of long-term loan

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Finished goods write off related to Dechra asset purchase

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of (discount) premium on marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

274

299

308

273

228

166

139

119

87

0

0

0

-

-

-

-

-

Depreciation and amortization expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Amortization of premium on marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Changes in operating assets and liabilities:
Accounts receivable

-31

20

559

937

275

903

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventories

-207

648

1,702

4,358

4,525

3,570

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other

1,963

825

56

346

554

867

553

-94

186

-485

27

711

322

570

438

456

271

235

-239

-78

18

329

327

487

572

147

360

0

0

0

Other assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Accounts payable

4,971

1,838

2,028

3,696

-71

277

880

-1,745

-673

1,280

-511

26

-101

-710

306

-872

220

30

-459

-610

-1,324

-269

619

1,676

1,669

683

125

0

0

0

Due to related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-5

4

0

0

0

Accrued liabilities and accrued compensation

-3,998

-5,038

-3,234

-4,695

1,175

2,802

2,014

4,005

1,850

1,368

1,500

816

651

955

-756

-281

-585

55

1,055

89

893

1,258

1,109

1,501

904

1,184

572

0

0

0

Net Cash Provided by (Used in) Operating Activities, Continuing Operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

Net cash used in operating activities

-54,800

-56,342

-55,525

-56,991

-52,467

-45,035

-37,941

-30,330

-27,235

-21,878

-20,611

-19,574

-18,162

-18,781

-19,793

-21,930

-22,838

-22,757

-22,362

-22,427

-23,544

-21,934

0

0

0

-

-

-

-

0

Cash Flows from Investing Activities
Purchases of investments

121,459

125,020

95,726

60,226

40,102

25,100

41,675

59,423

59,033

70,110

57,453

49,822

54,730

72,047

82,591

113,514

110,740

102,195

0

0

0

-

-

-

-

-

-

-

-

-

Sales of investments

-

-

-

-

-

800

2,801

2,801

4,097

4,897

2,896

2,896

1,600

0

0

0

0

3,000

0

0

0

-

-

-

-

-

-

-

-

-

Maturities of investments

105,797

82,628

66,378

37,499

39,300

54,575

63,075

69,895

76,830

68,465

57,765

59,096

65,383

78,313

112,174

137,924

138,801

129,361

0

0

0

-

-

-

-

-

-

-

-

-

Purchase of short-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

0

Sale of short-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

0

Maturities of short-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

0

Purchases of property and equipment

7,190

8,428

12,718

18,217

16,166

13,919

9,654

7,376

5,997

5,920

4,862

1,022

620

952

1,245

1,486

1,362

729

551

405

452

440

212

124

34

15

14

0

0

0

Proceeds from sale of property and equipment

2

5

73

73

251

248

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by (used in) investing activities

-19,851

-47,816

-38,994

-40,871

-16,717

16,604

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Net cash provided by investing activities

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

Cash Flows from Financing Activities
Exercises of stock options

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

Payment of restricted stock awards and units tax liability on net settlement

669

493

493

493

493

247

247

247

247

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net proceeds from note payable to related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

Net proceeds from initial public offering

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Net proceeds from sale of common stock

0

43,125

43,125

43,127

92,305

49,180

49,180

72,376

35,614

52,160

52,160

28,962

16,546

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

0

Proceeds from note payable to related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Net cash (used in) provided by financing activities

20,013

63,842

63,699

44,412

93,286

49,920

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Net change in cash and cash equivalents

-54,638

-40,316

-30,820

-53,450

24,102

21,489

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Exercise of stock options

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

2

0

0

0

Payment of initial public offering costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

Net change in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

30,315

20,810

10,255

-13,305

8,772

1,221

4,193

7,023

-3,785

5,484

-31,095

-52,360

-2,668

6,226

35,726

64,391

10,992

0

0

0

Cash paid for income taxes during the period

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

Supplemental disclosure of non-cash investing and financing activities:
Conversion of note payable into Series AA convertible preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Offering costs in connection with Series AA convertible preferred stock recorded in accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Conversion of Series AA, Series A-1 and Series A-1A preferred stock into shares of common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Purchases of property and equipment included in accounts payable and accrued liabilities

921

1,297

5,305

5,337

7,468

6,205

2,489

1,663

575

266

739

622

600

670

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

Proceeds due from sale of common stock

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-